KOPRAN LTD
KOPRAN · General/Diversified · NSE
₹161
Current Market Price
Fair Value (DCF)
₹82
Margin of Safety
-48.9%
Updated just now
YieldIQ Score
38/100
Piotroski F-Score
4/9
Economic Moat
Narrow
Confidence
26%
ROE
—
Debt/Equity
0.31
WACC
11.1%
Market Cap
₹778 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
10.7%
Return on capital employed
EV / EBITDA
16.2×
Enterprise multiple
Debt / EBITDA
2.7×
Leverage vs earnings
Interest Coverage
7.7×
EBIT covers interest
Current Ratio
1.76×
Short-term liquidity
Asset Turnover
0.75×
Revenue per ₹ of assets
Revenue CAGR (3Y)
9.9%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹161.19
Bear case
₹44.84
MoS -259.5%
Base case
₹82.35
MoS -95.7%
Bull case
₹110.67
MoS -45.6%
Ratio Trends
KOPRAN · last 9 annual periods
ROE
7.4%
ROCE
11.3%
Operating Margin
—
Debt / Equity
0.29×
PE
66.4×
EV / EBITDA
11.0×
Historical Financials
KOPRAN · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹492 Cr | ₹205 Cr | ₹149 Cr | ₹186 Cr | ₹630 Cr | +6.4% |
| EBITDA | — | ₹96.5 Cr | ₹53.3 Cr | ₹86.8 Cr | ₹75.3 Cr | -6.0% |
| EBIT | ₹89.6 Cr | ₹19.1 Cr | ₹12.7 Cr | ₹27.8 Cr | — | -25.4% |
| PAT | ₹61.6 Cr | ₹11.7 Cr | ₹8.0 Cr | ₹18.6 Cr | ₹38.6 Cr | -11.1% |
| EPS (diluted) | ₹14.24 | ₹2.65 | ₹1.67 | ₹3.85 | — | -27.9% |
| CFO | ₹60.0 Cr | ₹-37.8 Cr | ₹34.0 Cr | ₹43.2 Cr | ₹41.9 Cr | -8.6% |
| CapEx | — | — | — | — | ₹-58.9 Cr | — |
| FCF | — | — | — | — | ₹-17.0 Cr | — |
| Total Assets | — | ₹611 Cr | ₹650 Cr | ₹743 Cr | ₹844 Cr | +8.4% |
| Total Debt | — | — | ₹57.3 Cr | ₹82.6 Cr | ₹148 Cr | +26.7% |
| Shareholders' Equity | — | — | ₹439 Cr | ₹491 Cr | ₹518 Cr | +4.2% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
KOPRAN vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| AHCL ANLON HEALTHCARE LIMITED | -43.1% | 25 | Data Limited | 25.5% | — |
| MAXIND MAX INDIA LIMITED | -100.0% | 6 | Data Limited | -39.1% | — |
| TAKE TAKE SOLUTIONS LTD | -46.7% | 17 | Data Limited | — | — |
| ANUHPHR ANUHPHR | — | — | Pending | 14.5% | — |
| THEMISMED THEMISMED | — | — | Pending | 7.4% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for KOPRAN in the last 10 years.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of KOPRAN →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for KOPRAN →
Compare
Head-to-head with peers
Compare KOPRAN side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse KOPRANNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.